Page last updated: 2024-11-05

thalidomide and Amaurosis

thalidomide has been researched along with Amaurosis in 2 studies

Thalidomide: A piperidinyl isoindole originally introduced as a non-barbiturate hypnotic, but withdrawn from the market due to teratogenic effects. It has been reintroduced and used for a number of immunological and inflammatory disorders. Thalidomide displays immunosuppressive and anti-angiogenic activity. It inhibits release of TUMOR NECROSIS FACTOR-ALPHA from monocytes, and modulates other cytokine action.
thalidomide : A racemate comprising equimolar amounts of R- and S-thalidomide.
2-(2,6-dioxopiperidin-3-yl)-1H-isoindole-1,3(2H)-dione : A dicarboximide that is isoindole-1,3(2H)-dione in which the hydrogen attached to the nitrogen is substituted by a 2,6-dioxopiperidin-3-yl group.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Stefan, DC1
Andronikou, S1
Freeman, N1
Schoeman, J1
Schoeman, JF1
Fieggen, G1
Seller, N1
Mendelson, M1
Hartzenberg, B1

Other Studies

2 other studies available for thalidomide and Amaurosis

ArticleYear
Recovery of vision after adjuvant thalidomide in a child with tuberculous meningitis and acute lymphoblastic leukemia.
    Journal of child neurology, 2009, Volume: 24, Issue:2

    Topics: Adrenal Cortex Hormones; Antineoplastic Combined Chemotherapy Protocols; Blindness; Brain; Chemother

2009
Intractable intracranial tuberculous infection responsive to thalidomide: report of four cases.
    Journal of child neurology, 2006, Volume: 21, Issue:4

    Topics: Arachnoiditis; Blindness; Brain; Child; Child, Preschool; Disease Progression; Drug Therapy, Combina

2006